The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine
Open accessAbstract
BACKGROUND: In early 2000, a protein-polysaccharide conjugate vaccine targeting seven pneumococcal serotypes was licensed in the United States for use in young children. METHODS: We examined population-based data from the Active Bacterial Core Surveillance of the Centers for Disease Control and Prevention to evaluate changes in the burden of invasive disease, defined by isolation of Streptococcus pneumoniae from a normally sterile site. Serotyping and susceptibility testing of isolates were performed. We assessed trends using data from seven geographic areas with continuous participation from 1998 through 2001 (population, 16 million). RESULTS: The rate of invasive disease dropped from an average of 24.3 cases per 100,000 persons in 1998 and 1999 to 17.3 per 100,000 in 2001. The largest decline was in children under two years of age. In this group, the rate of disease was 69 percent lower in 2001 than the base-line rate (59.0 cases per 100,000 vs. 188.0 per 100,000, P<0.001); the rate of disease caused by vaccine and vaccine-related serotypes declined by 78 percent (P<0.001) and 50 percent (P<0.001), respectively. Disease rates also fell for adults; as compared with base line, the rate of disease in 2001 was 32 percent lower for adults 20 to 39 years of age (7.6 cases per 100,000 vs. 11.2 per 100,000, P<0.001), 8 percent lower for those 40 to 64 years of age (19.7 per 100,000 vs. 21.5 per 100,000, P=0.03), and 18 percent lower for those 65 years of age or more (49.5 per 100,000 vs. 60.1 per 100,000, P<0.001). The rate of disease caused by strains that were not susceptible to penicillin was 35 percent lower in 2001 than in 1999 (4.1 cases per 100,000 vs. 6.3 per 100,000, P<0.001). CONCLUSIONS: The use of the pneumococcal conjugate vaccine is preventing disease in young children, for whom the vaccine is indicated, and may be reducing the rate of disease in adults. The vaccine provides an effective new tool for reducing disease caused by drug-resistant strains.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Surveillance for Foodborne Disease Outbreaks—United States, 2006
(2010) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2009.11.004 · Cited by 2,361
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
BLACK, S., SHINEFIELD, H., FIREMAN, B., LEWIS, E., RAY, P., HANSEN, J. R., ELVIN, L., ENSOR, K. M., HACKELL, J., SIBER, G., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200003000-00003 · Cited by 2,293
Healthy People 2010: Understanding and Improving Health: (319432004-001)
US Department of Health & Human Services Office of Disease Prevention and Health Promotion (2000) · PsycEXTRA Dataset · doi:10.1037/e319432004-001 · Cited by 2,178
Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media
Eskola, J., Kilpi, T., Palmu, A., Jokinen, J., Eerola, M., Haapakoski, J., Herva, E., Takala, A., Käyhty, H., Karma, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102083440602 · Cited by 1,455
Increasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432603 · Cited by 888
Self-citationCigarette Smoking and Invasive Pneumococcal Disease
Nuorti, J. P., Butler, J. C., Farley, M. M., Harrison, L. H., McGeer, A., Kolczak, M. S., & Breiman, R. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421002 · Cited by 798
Self-citationBLACK, S. B., SHINEFIELD, H. R., LING, S., HANSEN, J., FIREMAN, B., SPRING, D., NOYES, J., LEWIS, E., RAY, P., LEE, J., et al. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200209000-00005 · Cited by 616
Immunogenicity and Impact on Nasopharyngeal Carriage of a Nonavalent Pneumococcal Conjugate Vaccine
Mbelle, N., Huebner, R. E., Wasas, A. D., Kimura, A., Chang, I., & Klugman, K. P. (1999) · The Journal of Infectious Diseases · doi:10.1086/315009 · Cited by 515
Dagan, R., Melamed, R., Muallem, M., Piglansky, L., Greenberg, D., Abramson, O., Mendelman, P. M., Bohidar, N., & Yagupsky, P. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1271 · Cited by 477
Committee on Infectious Diseases (2000) · Pediatrics · doi:10.1542/peds.106.2.362 · Cited by 390
Dagan, R., Givon‐Lavi, N., Zamir, O., Sikuler‐Cohen, M., Guy, L., Janco, J., Yagupsky, P., & Fraser, D. (2002) · The Journal of Infectious Diseases · doi:10.1086/339525 · Cited by 339
Carriage of pneumococci after pneumococcal vaccination
Obaro, S. K., Adegbola, R., Banya, W., & Greenwood, B. (1996) · The Lancet · doi:10.1016/s0140-6736(05)65585-7 · Cited by 325
Performance standards for antimicrobial susceptibility testing : twelfth informational supplement
Ferraro, M. J. (2002) · Medical Entomology and Zoology · Cited by 316
Spread of Streptococcus pneumoniae in Families. I. Carriage Rates and Distribution of Types
Owen Hendley, J., Sande, M. A., Stewart, P. M., & Gwaltney, J. M. (1975) · Journal of Infectious Diseases · doi:10.1093/infdis/132.1.55 · Cited by 285
Principles of Judicious Use of Antimicrobial Agents for Pediatric Upper Respiratory Tract Infections
Dowell, S. F., Marcy, S. M., Phillips, W. R., Gerber, M. A., & Schwartz, B. (1998) · Pediatrics · doi:10.1542/peds.101.s1.163 · Cited by 275
Gonzales, R., Bartlett, J. G., Besser, R. E., Cooper, R. J., Hickner, J. M., Hoffman, J. R., & Sande, M. A. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-6-200103200-00013 · Cited by 251
Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine
BLACK, S. B., SHINEFIELD, H. R., HANSEN, J., ELVIN, L., LAUFER, D., & MALINOSKI, F. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200112000-00002 · Cited by 242
DAGAN, R., MUALLEM, M., MELAMED, R., LEROY, O., & YAGUPSKY, P. (1997) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199711000-00011 · Cited by 217
Breiman, R. F., Keller, D. W., Phelan, M. A., Sniadack, D. H., Stephens, D. S., Rimland, D., Farley, M. M., Schuchat, A., & Reingold, A. L. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.17.2633 · Cited by 171
Self-citation
Cited by
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
Self-citationBradley, J. S., Byington, C. L., Shah, S. S., Alverson, B., Carter, E. R., Harrison, C., Kaplan, S. L., Mace, S. E., McCracken, G. H., Moore, M. R., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir531 · Cited by 1,919
Clinical features and prognostic factors in adults with bacterial meningitis
van de Beek, D., de Gans, J., Spanjaard, L., Weisfelt, M., Reitsma, J. B., & Vermeulen, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040845 · Cited by 1,639
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Pilishvili, T., Lexau, C., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Reingold, A., Thomas, A., Schaffner, W., Craig, A. S., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/648593 · Cited by 1,311
Self-citationStreptococcus pneumoniae: transmission, colonization and invasion
Weiser, J. N., Ferreira, D. M., & Paton, J. C. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0001-8 · Cited by 1,098
Metadata
- Authors
- Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., Facklam, R. R., Jorgensen, J. H., & Schuchat, A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-05
- Volume
- 348
- Issue
- 18
- Pages
- 1737-1746
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2103637444
- Cited by
- 2,228
- References
- 20
- FWCI
- 105.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.